<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>34-AMLODIPINE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="AMLODIPINE" rxcui="17767">
<ATC code="C08CA01" />
<ATC code="C09BB04" />
<ATC code="C09DB01" />
<ATC code="C09DB02" />
<ATC code="C10BX03" />
<ATC code="C09BB03" />
<ATC code="C09DB04" />
<ATC code="C09DX01" />
<ATC code="C08GA02" />
<ATC code="C09BX01" />
<ATC code="C09DB07" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="SIMVASTATIN" rxcui="36567">
<ATC code="C10AA01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increased risk of undesirable effects (dose dependent) of the rhabdomyolysis type (decrease of the hepatic metabolism of the cholesterol lowering medication).</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Do not exceed the dosage of 40 mg/day of simvastatin or use another statin not affected by this type of interaction</COMMENT>
</INTERACTION>
</INTERACTIONS>
